REVERSED
Tech Center 1600 Biotechnology and Organic Chemistry
1624 Ex Parte Goldstein et al 11899758 - (D) POLLOCK 103 Hoffmann-La Roche Inc. C/O Gibbons P.C. RAO, DEEPAK R
The Federal Circuit provides a two-prong analysis to determine whether a new chemical compound is prima facie obvious over particular prior art. The fact finder first determines whether a chemist of ordinary skill would have selected the asserted prior art compounds as lead compounds, or starting points, for further development efforts. (Otsuka Pharm. Co. v. Sandoz Inc., 678 F.3d 1280, 1291 (Fed. Cir. 2012). The Court defines a lead compound as “a compound in the prior art that would be most promising to modify in order to improve upon its ... activity and obtain a compound with better activity,” (Takeda Chem. Indus., Ltd. v. Alphapharm Pty., Ltd., 492 F.3d 1350, 1357 (Fed. Cir. 2007), or “a natural choice for further development efforts.” Altana Pharma AG v. Teva Pharm. USA, Inc., 566 F.3d 999, 1008 (Fed. Cir. 2009). The second step involves determining “whether the prior art would have supplied one of ordinary skill in the art with a reason or motivation to modify a lead compound to make the claimed compound with a reasonable expectation of success.” Otsuka, 678 F.3d at 1292 (citing Takeda, 492 F.3d at 1357).
Tech Center 2100 Computer Architecture and Software
2166 Ex Parte Muras 12105774 - (D) WORMEESTER 103 WOOD, HERRON & EVANS, L.L.P. (IBM) LIN, SHEW FEN
Tech Center 2600 Communications
2672 Ex Parte Umekage et al 10572421 - (D) ADAMS 103 EDWARDS WILDMAN PALMER LLP PACHOL, NICHOLAS C
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2842 Ex Parte Kim et al 11198596 - (D) KRATZ 103 BLAKELY SOKOLOFF TAYLOR & ZAFMAN CHENG, DIANA
AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1765 Ex Parte Weikard et al 11217725 - (D) GRIMES 103 obviousness-type double patenting NOVAK DRUCE CONNOLLY BOVE + QUIGG LLP SERGENT, RABON A
2474 Ex Parte Chaudhry et al 12144120 - (D) HUME 112(2)/102(e) WALL & TONG, LLP/ALCATEL-LUCENT USA INC. ELLIOTT IV, BENJAMIN H
Tech Center 2600 Communications
2695 Ex Parte Wallash et al 11701091 - (D) DANG 103 HGST C/O WAGNER BLECHER LLP WATKO, JULIE ANNE
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2883 Ex Parte Helvenstein 12077186 - (D) GARRIS 103 SOFER & HAROUN LLP. TAVLYKAEV, ROBERT FUATOVICH
REEXAMINATION
AFFIRMED
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3711 Ex parte AINSWORTH GAME TECHNOLOGY LIMITED Appellant, Patent Owner Ex Parte 6,544,120 et al 09/862,182 90012063 - (D) BAHR 112(1)/102/103 112(2) MARSHALL, GERSTEIN & BORUN LLP THIRD PARTY REQUESTER: MCANDREWS HELD & MALLOY, LTD ENGLISH, PETER C original LAYNO, BENJAMIN
